Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Zoledronate|DRUG: Atorvastatin 80mg|DRUG: Standard neoadjuvant cht
Sponsor: Mario Negri Institute for Pharmacological Research
Collaborators: Associazione Italiana per la Ricerca sul Cancro